ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BAYRY Bayer Aktiengesellschaft (PK)

7.36
0.06 (0.82%)
01 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Bayer Aktiengesellschaft (PK) USOTC:BAYRY OTCMarkets Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.06 0.82% 7.36 7.36 7.45 7.52 7.12 7.38 836,713 21:21:00

Bayer Served With Fresh Roundup Suit in Australia

04/06/2019 2:34pm

Dow Jones News


Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Bayer Aktiengesellschaft (PK) Charts.
   By Nathan Allen 
 

Bayer AG (BAYN.XE) faces a fresh lawsuit in Australia after a Victoria-based gardener filed papers alleging the company's Roundup weedkillers caused him to develop a type of lung cancer, the plaintiff's lawyers said Tuesday.

Carbone Lawyers, which is representing Michael Ogalirolo in the case, said the proceedings were the first of their kind in Australia. The law firm said Mr. Ogalirolo developed non-Hodgkin's lymphoma after being exposed to Bayer's glyphosate-based products for over 20 years as a self-employed landscape gardener.

Bayer said in a statement that it is aware of media reports regarding a lawsuit in Australia but it hadn't yet received any formal notification.

"We have great sympathy for any individual with cancer, but the extensive body of science on glyphosate-based herbicides over four decades supports the conclusion that Roundup does not cause non-Hodgkin's Lymphoma," the company said.

The German chemical group took over Roundup manufacturer Monsanto Co. and its associated legal liabilities in 2018 for $63 billion. It now faces around 13,400 claims for glyphosate damages in the U.S. and has already been ordered to pay billions of dollars to plaintiffs by juries in California.

Analysts expect the company to eventually reach an out-of-court settlement but have struggled to assess the scale of the total liabilities.

 

Write to Nathan Allen at nathan.allen@dowjones.com

 

(END) Dow Jones Newswires

June 04, 2019 09:19 ET (13:19 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Bayer Aktiengesellschaft (PK) Chart

1 Year Bayer Aktiengesellschaft (PK) Chart

1 Month Bayer Aktiengesellschaft (PK) Chart

1 Month Bayer Aktiengesellschaft (PK) Chart

Your Recent History

Delayed Upgrade Clock